Outi M. H. Salo‐Ahen

Author

Also Known As

O. Salo, O. Salo-Ahen, O.M.H. Salo-Ahen, Outi M H Salo, Outi M. H. Salo, Outi M. H. Salo-Ahen, Outi M. H. Salo‐Ahen, Outi M.H. Salo, Outi M.H. Salo-Ahen, Outi MH Salo-Ahen

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Åbo Akademi University University of Turku University of Eastern Finland Heidelberg Institute for Theoretical Studies Rega Institute for Medical Research

About

Outi M. H. Salo‐Ahen is an author at Åbo Akademi University specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1K
2	Biochemistry	9	9	988
3	Natural Sciences	7	7	401
4	Engineering	4	4	706
5	Allergy	1	1	12

Outi M. H. Salo‐Ahen

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development Outi M. H. Salo‐Ahen, Ida Alanko, Rajendra Bhadane, Processes Drug TargetEngineeringMd MethodologiesBiochemistryMedicine	2020	580
Computational approaches to identifying and characterizing protein binding sites for ligand design Stefan Henrich, Outi M. H. Salo‐Ahen, Bingding Huang, Journal of Molecular Recognition	2009	216
Characterization of the Sulfhydryl-Sensitive Site in the Enzyme Responsible for Hydrolysis of 2- Arachidonoyl-Glycerol in Rat Cerebellar Membranes Susanna M. Saario, Outi M. H. Salo‐Ahen, Tapio Nevalainen, Chemistry & Biology Proteinlipid InteractionRat Cerebellar MembranesEnzyme ResponsibleCellular EnzymologyBiochemistry	2005	156
Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins Muhammad Usman Mirza, Shazia Rafique, Amjad Ali, Scientific Reports	2016	136
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL <sup>pro</sup> Mubarak A. Alamri, Muhammad Tahir ul Qamar, Muhammad Usman Mirza, Journal of Biomolecular Structure and Dynamics	2020	124
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase Daniela Cardinale, Giambattista Guaitoli, Donatella Tondi, Proceedings of the National Academy of Sciences Peptide EngineeringMolecular BiologyPeptide TherapeuticsChemical BiologyHuman Thymidylate Synthase	2011	103
Development of a 3D Model for the Human Cannabinoid CB1 Receptor Outi M. H. Salo‐Ahen, Maija Lahtela‐Kakkonen, Jukka Gynther, Journal of Medicinal Chemistry	2004	70
Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy Jiaqi Yan, Rajendra Bhadane, Meixin Ran, Nature Communications	2024	65
Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis Basit Jabbar, Shazia Rafique, Outi M. H. Salo‐Ahen, Frontiers in Immunology EngineeringImmunologyPathologyAntigen ProcessingImmunotherapy	2018	60
Fatty Acid Amide Hydrolase Inhibitors from Virtual Screening of the Endocannabinoid System Susanna M. Saario, Antti Poso, Risto O. Juvonen, Journal of Medicinal Chemistry	2006	59

Page 1